KalVista Pharmaceuticals (KALV) Prepaid Assets (2014 - 2025)

KalVista Pharmaceuticals (KALV) reported Prepaid Assets of $1.5 million for Q3 2025, down 52.67% on a YoY basis from $3.1 million in Q3 2024, and down 71.61% sequentially from $5.1 million in Q2 2025.

KalVista Pharmaceuticals (KALV) Prepaid Assets (2014 - 2025) Analysis & Trends

KalVista Pharmaceuticals (KALV) has 12 years of Prepaid Assets data on file, last reported at $1.5 million in Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets fell 52.67% year-over-year to $1.5 million; the trailing twelve-month figure through Jul 2025 stood at $1.5 million (down 52.67% YoY), and the FY2025 full-year result was $5.1 million, up 223.34% from the prior year.
  • Prepaid Assets declined to $1.5 million in Q3 2025, from $5.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $8.6 million in Q1 2023 to a low of $807000.0 in Q4 2024.
  • A 5-year average of $4.4 million and a median of $4.6 million in 2021 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets soared 378.97% in 2021 and slumped 78.13% in 2024, its largest moves.
  • Tracing KALV's Prepaid Assets over 5 years: stood at $7.3 million in 2021, then plunged by 73.69% to $1.9 million in 2022, then gained by 23.01% to $2.4 million in 2023, then soared by 164.33% to $6.2 million in 2024, then sank by 76.6% to $1.5 million in 2025.
  • Business Quant data shows KALV's Prepaid Assets at $1.5 million in Q3 2025, $5.1 million in Q2 2025, and $6.2 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 KalVista Pharmaceuticals 1.36 Bn 1.36 Bn 49.41 Mn

Historic Data

Download Data
DateValue
Jul 31, 2025 1.46 Mn
Apr 30, 2025 5.13 Mn
Dec 31, 2024 6.22 Mn
Oct 31, 2024 807,000.00
Jul 31, 2024 3.07 Mn
Apr 30, 2024 1.59 Mn
Jan 31, 2024 1.87 Mn
Oct 31, 2023 2.35 Mn
Jul 31, 2023 2.84 Mn
Apr 30, 2023 6.38 Mn
Jan 31, 2023 8.56 Mn
Oct 31, 2022 1.91 Mn
Jul 31, 2022 2.33 Mn
Apr 30, 2022 8.40 Mn
Jan 31, 2022 8.39 Mn
Oct 31, 2021 7.27 Mn
Jul 31, 2021 5.54 Mn
Apr 30, 2021 4.92 Mn
Jan 31, 2021 4.60 Mn
Oct 31, 2020 1.52 Mn